The role of hyperbaric oxygen therapy in the management of autism
Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante
Record ID 32007000637
French
Authors' recommendations:
Upon the completion of this systematic literature review, we observe that this is a topic of recent interest. The scientifi c data available at this time are of low quality, and the level of evidence does not enable one to build a strong case for the efficacy of this treatment modality in managing autistic disorder. The five ongoing studies identified are examining this matter from different perspectives. However, the differences in the HBO protocols and the small patient samples raise questions and foreshadow mixed results, which could compromise these studies- validity. In these circumstances, a literature watch should be conducted to evaluate the results of these studies as soon as they are published. In short, for the management of autism, hyperbaric oxygen therapy should, for now, be considered an experimental treatment modality. Consequently, in Quwbec, it should be limited to formal research projects.
Details
Project Status:
Completed
URL for project:
http://www.aetmis.gouv.qc.ca/site/en_publications_2007.phtml
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Hyperbaric Oxygenation
- Autistic Disorder
Contact
Organisation Name:
Agence d'évaluation des technologies et des modes d'intervention en santé
Contact Address:
2021, avenue Union, Bureau 10.083,Montreal, Quebec H3A S29, Canada.Tel: +1 514 873 2563; Fax: +1 514 873 1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.